Venetoclax use in a patient with ataxia telangiectasia and early T-cell precursor acute lymphoblastic leukemia

Pediatr Blood Cancer. 2024 Aug;71(8):e31123. doi: 10.1002/pbc.31123. Epub 2024 Jun 5.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antineoplastic Agents / therapeutic use
  • Ataxia Telangiectasia* / complications
  • Ataxia Telangiectasia* / drug therapy
  • Bridged Bicyclo Compounds, Heterocyclic* / administration & dosage
  • Bridged Bicyclo Compounds, Heterocyclic* / therapeutic use
  • Child
  • Female
  • Humans
  • Male
  • Precursor T-Cell Lymphoblastic Leukemia-Lymphoma* / complications
  • Precursor T-Cell Lymphoblastic Leukemia-Lymphoma* / drug therapy
  • Precursor T-Cell Lymphoblastic Leukemia-Lymphoma* / pathology
  • Sulfonamides* / administration & dosage
  • Sulfonamides* / therapeutic use

Substances

  • Bridged Bicyclo Compounds, Heterocyclic
  • venetoclax
  • Sulfonamides
  • Antineoplastic Agents